PEG-MGF (PEGMGF)

Muscle Research chemical

PEGylated version of MGF with dramatically extended half-life, allowing systemic rather than site-specific effects.

Key Data

Research Status
Research chemical
Half-Life
Several days
Administration
Subcutaneous injection
Typical Dosage
200 mcg 2-3x per week

Mechanism of Action

Same as MGF with PEG attachment for extended circulation time and systemic distribution.

Reported Benefits

All information is presented for Research Use Only (RUO). Not medical advice.

← All Peptides Dosing Calculator Community Forum Home